Hypertensive encephalopathy and the blood-brain barrier: Is δPKC a gatekeeper?

Journal of Clinical Investigation

Volumn 118, Issue 1, 2008, Pages 17-20

  Chou, Wen Hai ^a   Messing, Robert O ^a  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C DELTA;

AUTOREGULATION; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; ENDOTHELIUM CELL; HYPERTENSION ENCEPHALOPATHY; MORTALITY; NONHUMAN; NOTE; PERICYTE; PRIORITY JOURNAL; SATELLITE CELL;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; HYPERTENSIVE ENCEPHALOPATHY; MALE; OLIGOPEPTIDES; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; TIGHT JUNCTIONS;

EID: 38149094383     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI34516     Document Type: Note

References (18)

1. Cecchelli, R., et al. 2007. Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 6:650-661.
2. Hawkins, B.T., and Davis, T.P. 2005. The blood-brain barrier/ neurovascular unit in health and disease. Pharmacol. Rev. 57:173-185.
3. Mark, K.S., and Davis, T.P. 2002. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 282:H1485-H1494.
4. Harhaj, N.S., and Antonetti, D.A. 2004. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell. Biol. 36:1206-1237.
5. Abbott, N.J., Ronnback, L., and Hansson, E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7:41-53.
6. Blumenfeld, J.D., et al. 2001. Renin system activation and delayed function of the renal transplant. Am. J. Hypertens. 14:1270-1272.
7. Steinberg, S.F. 2004. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem. J. 384:449-459.
8. Mochly-Rosen, D. 1995. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science. 268:247-251.
9. Schwarze, S.R., Ho, A., Vocero-Akbani, A., and Dowdy, S.F. 1999. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1569-1572.
10. Qi, X., Inagaki, K., Sobel, R.A., and Mochly-Rosen, D. 2008. Sustained pharmacological inhibition of ?PKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. J. Clin. Invest. 118:173-182.
11. Chen, L., et al. 2001. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc. Natl. Acad. Sci. U. S. A. 98:11114-11119.
12. Inagaki, K., et al. 2003. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation. 108:2304-2307.
13. Murriel, C.L., Churchill, E., Inagaki, K., Szweda, L.I., and Mochly-Rosen, D. 2004. Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J. Biol. Chem. 279:47985-47991.
14. Ikeno, F., Inagaki, K., Rezaee, M., and Mochly-Rosen, D. 2007. Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage. Cardiovasc. Res. 73:699-709.
15. Bright, R., et al. 2004. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J. Neurosci. 24:6880-6888.
16. Bright, R., Steinberg, G.K., and Mochly-Rosen, D. 2007. DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res. 1144:146-155.
17. Shimohata, T., et al. 2007. Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J. Cereb. Blood Flow Metab. 27:1463-1475.
18. Allen, J.J., et al. 2007. A semisynthetic epitope for kinase substrates. Nat. Methods. 4:511-516.